Abraxis Bioscience LLC v Comptroller General of Patents.

Core Citations

WORK EXPRESSION OF in

• Abraxis Bioscience LLC v Comptroller General of Patents.

This document cites

• F. Hoffmann-La Roche Ltd and Others v Autorità Garante della Concorrenza e del Mercato.
• Glaxosmithkline Biologicals SA and Glaxosmithkline Biologicals, Niederlassung der Smithkline Beecham Pharma GmbH & Co. KG v Comptroller General of Patents, Designs and Trade Marks.
• Medeva BV v Comptroller General of Patents, Designs and Trade Marks.
• Neurim Pharmaceuticals (1991) Ltd v Comptroller-General of Patents.
• Council Regulation (EEC) No 1768/92 of 18 June 1992 concerning the creation of a supplementary protection certificate for medicinal products



See all quotations

• Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use
• Regulation (EC) No 469/2009 of the European Parliament and of the Council of 6 May 2009 concerning the supplementary protection certificate for medicinal products (Codified version) (Text with EEA relevance)
• Rules of Procedure of the Court of Justice
• Consolidated version of the Treaty on the Functioning of the European Union 2016/C 202/01
• Directive 2001/82/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to veterinary medicinal products
• Treaty establishing the European Community